Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Michael Frede: A Free Will. Origins of the Notion in Ancient Thought. Edited by A. A. Long with a Foreword by David Sedley.
View through CrossRef
Michael Frede: A Free Will. Origins of the Notion in Ancient Thought. Edited by A. A. Long with a Foreword by David Sedley. Berkeley/Los Angeles/London: California UP 2011. XIV, 206 S. (Sather Classical Lectures. 68. The Joan Palevsky Imprint in Classical Literature.) 34,95 £.
Title: Michael Frede: A Free Will. Origins of the Notion in Ancient Thought. Edited by A. A. Long with a Foreword by David Sedley.
Description:
Michael Frede: A Free Will.
Origins of the Notion in Ancient Thought.
Edited by A.
A.
Long with a Foreword by David Sedley.
Berkeley/Los Angeles/London: California UP 2011.
XIV, 206 S.
(Sather Classical Lectures.
68.
The Joan Palevsky Imprint in Classical Literature.
) 34,95 £.
Related Results
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
IMPORTANCE
Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
BACKGROUND:
ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) did not find an overall reduction in cardiovascular ...
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Importance
The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown.
...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...